Assay Development for Histone Methyltransferases. Assay and Drug Development Technologies, 2013 by Andrew Khouri | Jul 6, 2023
Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader. ChemRxiv, 2021 by Andrew Khouri | Jul 6, 2023
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors. Nature Communications, 2017 by Andrew Khouri | Jul 6, 2023
Histone Methyltransferase Activity Assay. Epigenetics for Drug Discovery, 2016 by Andrew Khouri | Jul 6, 2023
A novel orally active HDAC6 inhibitor T‑518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice. Scientific Reports, 2021 by Andrew Khouri | Jul 6, 2023